In 2023, Sentum started offering white-label production and R&D services. It provided us the opportunity to conduct several large external projects in 2023 (Research, development, branding). The target specifications were designed to control mood.

We conducted extensive research in the field of mood modulation products with a target psychological effect. In 2024, Sentum continues working in this area to launch new products under the SENTUM brand in the market. With the fast-growing problem of psychological states after COVID and in an era of a fast-changing environment, our company sees a strong potential in the field of supplements for psychological well-being.

The second field we are actively seeking to pursue is contract manufacturing, R&D, and branding. We have modern and strong expertise in product development in the life science industry. Market analysis, market fit, product research, design research, claims, branding, packaging, logistics, formula development, trials, marketing, sales – all these areas are our expertise (food supplements). We aim to grow the quantity of our partners around Europe and continue to help new and existing companies launch successful products in the market.

Also, the year 2024 is a year for a financial round closure. We aim to close our next financial round to grow at a stronger rate. The financials will be used to invest in new product development and further marketing.